With the emergence of increased GLP-1 use and alternative PBM models, Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, joined Drug Topics to discuss current trends in drug benefit design.
Scott Halperin, PharmD
Advertisement
Articles by Scott Halperin, PharmD
Pharmaceutical Strategies Group experts joined Drug Topics to discuss the role GLP-1s play in drug benefit design.
Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss how the role of PBMs in plan design is evolving.
Morgan Lee, PhD, MPH, CPH, and Scott Halperin, PharmD, from the Pharmaceutical Strategies Group, discuss the 2025 Trends in Drug Benefit Design Report and how it will impact pharmacists.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Drug Topics
1
Pneumococcal Vaccine Rates for Black Adults Significantly Higher Than White Adults
2
Pharmacists Guide Pneumonia Treatment, Safety, and Vaccination
3
Infectious Disease Pharmacist Breaks Down Pneumonia Types, Treatment Options
4
New Data Show Semaglutide’s Liver Benefits Not Exclusively Tied to Weight Loss
5
